↓ Skip to main content

ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country.

Overview of attention for article published in Revista de Salud Pública, May 2014
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
95 Mendeley